Traduction de «number of which » (Néerlandais → Français) :

In 2007, 60 formal scientific opinions were issued, a number of which were further coordinated by the Belgian delegation in the SAWP.
In 2007, 60 formal scientific opinions were issued, a number of which were further coordinated by the Belgian delegation in the SAWP.

These impacts however were more than offset by a number of positive factors, including: Marketing & Sales costs, which were lower by 0.4 percentage points due to productivity improvements partly offset by investments in growth areas; R&D costs, which decreased (improving +1.2 percentage points) as productivity savings funded continued investment in the development of differentiated generics; General & Administration costs, which decreased (+1.1 percentage points) due to ongoing cost reduction measures; and Other Income and Expenses, which were positive at 0.5 percentage points due to lower legal fees.
Cependant, ces impacts ont été plus que compensés par un certain nombre de facteurs positifs, notamment: une baisse de 0,4 point de pourcentage des coûts de Marketing et vente due à des gains de productivité en partie contrebalancés par des investissements dans des domaines en pleine croissance; une diminution des coûts de Recherche et développement (amélioration +1,2 point), des gains de productivité servant à financer des investissements continus dans le développement de génériques différenciés; un abaissement des coûts d’Administration et frais généraux (+1,1 point) grâce à des mesures continues de réduction des coûts; une progression de 0,5 point d'Autres produits et charges suite à une baisse des frais juridiques.

However, such medicines do have to meet a number of quality and efficacy conditions, which are investigated in connection with the ED.
However, such medicines do have to meet a number of quality and efficacy conditions, which are investigated in connection with the ED.

Reactions and events reported in 2006 were analysed and summarized in a first annual report which gives an overview of the notifications, the most important findings and a number of recommendations ●● In 2007 a total of 848 reactions and events
Reactions and events reported in 2006 were analysed and summarized in a first annual report which gives an overview of the notifications, the most important findings and a number of recommendations ●● In 2007 a total of 848 reactions and events

However, if a medicine is being administered for which there is no MA, a minimum number of quality standards need to be put in place and a minimum guarantee needs to be provided through the animal tests conducted or existing experience with humans, suggesting that the
However, if a medicine is being administered for which there is no MA, a minimum number of quality standards need to be put in place and a minimum guarantee needs to be provided through the animal tests conducted or existing experience with humans, suggesting that the

A list of potential substantive (vertical) and processrelated (horizontal) spearheads was drawn up and a number of criteria were determined by which the different areas could be compared with one another.
A list of potential substantive (vertical) and processrelated (horizontal) spearheads was drawn up and a number of criteria were determined by which the different areas could be compared with one another.

A growing number of patients are returning for treatment with this medicine, which is known as Reclast in the US and Aclasta in the rest of the world.
Un nombre grandissant de malades reviennent pour être traités avec ce médicament connu sous la marque Reclast aux Etats-Unis et Aclasta dans le reste du monde.

At the end of the first three months, which are considered as the most dangerous, the number of new attempts is almost zero amongst the suicidal persons taken care of by the CIP.
A l’échéance de trois mois, période considérée comme la plus à risque, le taux de récidive est proche de 0 chez les suicidants pris en charge par la CIP.

Chiron/Fluvirin The former Chiron Corporation, which Novartis acquired during 2006, was the subject of a number of legal proceedings arising out of Chiron’s inability to deliver its Fluvirin influenza vaccine to the US market for the 2004/05 flu season, including class-action lawsuits alleging breaches of securities laws and shareholder derivative lawsuits alleging breaches of fiduciary duties.
Fluvirin de Chiron L’ancien groupe Chiron Corporation, racheté par Novartis au cours de 2006, faisait l’objet de plusieurs actions en justice en rapport avec son incapacité à fournir le vaccin anti-grippe Fluvirin sur le marché américain pour la saison grippale 2004/05.

In anticipation of changes to the product portfolio in the US, which includes expected approvals for a number of new specialty medicines but also the loss of market exclusivity for Diovan and other medicines in the next few years, Novartis has further streamlined its US business in Pharmaceuticals to maximize the potential of the changing portfolio in both primary care and specialty markets.
Novartis anticipe les changements qui vont intervenir au cours des années à venir dans son portefeuille de produits aux Etats-Unis, notamment les autorisations attendues pour de nouvelles spécialités mais aussi la perte de l’exclusivité du marché pour Diovan et d’autres médicaments. C’est ainsi que Pharmaceuticals a encore rationalisé ses opérations américaines pour maximiser le potentiel d’un portefeuille en plein changement, à la fois dans les soins de santé primaires et dans les marchés des spécialités.